These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21900791)

  • 1. Are we entering a new era in melanoma treatment? Lesson from ASCO 2011.
    Mouawad R; Spano JP; Khayat D
    Melanoma Res; 2011 Oct; 21(5):377-9. PubMed ID: 21900791
    [No Abstract]   [Full Text] [Related]  

  • 2. [New hope in metastatic melanoma treatment?].
    Guillot B
    Ann Dermatol Venereol; 2012 Oct; 139(10):693-4. PubMed ID: 23122388
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metastatic melanoma: some hope from ipilimumab and vemurafenib].
    Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2012 Feb; 67(2):64-8. PubMed ID: 22482234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies for the treatment of metastatic melanoma.
    Chouake J; Friedman A
    J Drugs Dermatol; 2012 Feb; 11(2):271-3. PubMed ID: 22270215
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves new melanoma treatments.
    Johns Hopkins Med Lett Health After 50; 2012 Jan; 23(11):3. PubMed ID: 22396993
    [No Abstract]   [Full Text] [Related]  

  • 6. Advances in the treatment of melanoma.
    Lacy KE; Karagiannis SN; Nestle FO
    Clin Med (Lond); 2012 Apr; 12(2):168-71. PubMed ID: 22586796
    [No Abstract]   [Full Text] [Related]  

  • 7. Strides in melanoma announced: maximizing value comes next.
    Tuma RS
    J Natl Cancer Inst; 2011 Jul; 103(13):997-9. PubMed ID: 21693727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of metastatic melanoma: are we entering the era of targeted treatment?].
    von Moos R; Cathomas R; Mark M; Hitz F
    Praxis (Bern 1994); 2012 Oct; 101(22):1423-9. PubMed ID: 23117962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted therapies for metastatic melanoma.
    Chandra S; Pavlick AC
    Dermatol Clin; 2012 Jul; 30(3):517-24. PubMed ID: 22800555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Zelboraf. Longer term survival for advanced stage melanoma].
    Sabourin G
    Perspect Infirm; 2012; 9(5):64-5. PubMed ID: 22978138
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry makes strides in melanoma.
    Garber K
    Nat Biotechnol; 2010 Aug; 28(8):763-4. PubMed ID: 20697383
    [No Abstract]   [Full Text] [Related]  

  • 12. Current advances and perspectives in the treatment of advanced melanoma.
    Livingstone E; Zimmer L; Vaubel J; Schadendorf D
    J Dtsch Dermatol Ges; 2012 May; 10(5):319-25. PubMed ID: 22432863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant treatment of a solitary melanoma brain metastasis with vemurafenib.
    Kolar GR; Miller-Thomas MM; Schmidt RE; Simpson JR; Rich KM; Linette GP
    J Clin Oncol; 2013 Jan; 31(3):e40-3. PubMed ID: 23233711
    [No Abstract]   [Full Text] [Related]  

  • 14. [New treatment options for metastatic melanoma].
    Tietze JK; Berking C
    Dtsch Med Wochenschr; 2014 Jul; 139(28-29):1462-7. PubMed ID: 24983194
    [No Abstract]   [Full Text] [Related]  

  • 15. [New molecular target therapy for thyroid neoplasms and malignant melanomas].
    Okano S
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Nov; 118(11):1366-7. PubMed ID: 26891495
    [No Abstract]   [Full Text] [Related]  

  • 16. What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma?
    Donnelly OG; Melcher AA; Vile RG; Pulido J
    Immunotherapy; 2012 Aug; 4(8):749-51. PubMed ID: 22947000
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma.
    Anker CJ; Ribas A; Grossmann AH; Chen X; Narra KK; Akerley W; Andtbacka RH; Noyes RD; Shrieve DC; Grossmann KF
    J Clin Oncol; 2013 Jun; 31(17):e283-7. PubMed ID: 23650406
    [No Abstract]   [Full Text] [Related]  

  • 18. Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib.
    Gerami P; Sorrell J; Martini M
    J Am Acad Dermatol; 2012 Dec; 67(6):e275-6. PubMed ID: 23158636
    [No Abstract]   [Full Text] [Related]  

  • 19. Regression of orbital and choroidal metastases from melanoma after treatment with vemurafenib.
    Ngo E; Hutchins LF; Gardner JM; Uwaydat SH
    Can J Ophthalmol; 2014 Apr; 49(2):e49-52. PubMed ID: 24767240
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathological features of cutaneous drug reactions to vemurafenib: a report of two cases.
    Dabner M; Harvey NT; Soma A; Wood BA
    Pathology; 2012 Dec; 44(7):661-4. PubMed ID: 23172086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.